Travere Therapeutics
TVTX
#3221
Rank
ยฃ3.53 B
Marketcap
ยฃ36.83
Share price
-3.86%
Change (1 day)
35.77%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2026 (TTM): -ยฃ0.97

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.98. In 2025 the company made an earnings per share (EPS) of -ยฃ0.22 an increase over its 2024 EPS that were of -ยฃ3.13.

EPS history for Travere Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.97340.34%
2025-ยฃ0.22-92.93%
2024-ยฃ3.13154.66%
2023-ยฃ1.23-63.16%
2022-ยฃ3.3344.22%
2021-ยฃ2.31-10.09%
2020-ยฃ2.57
2018-ยฃ1.9464.94%
2017-ยฃ1.17
2015ยฃ2.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-ยฃ0.14-85.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ0.72-26.36%๐Ÿ‡บ๐Ÿ‡ธ USA